Show pageOld revisionsBacklinksFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ======= PRNP ======= == Gene Information == * **<color #00a2e8>Official Symbol</color>**: PRNP * **<color #00a2e8>Official Name</color>**: prion protein * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5621|5621]] * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/"F7VJQ1|P04156"|"F7VJQ1|P04156"]] * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=PRNP&organism=9606|BioGRID]] * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PRNP|Open PubMed]] * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/176640|Open OMIM]] == Function Summary == * **<color #00a2e8>Entrez Summary</color>**: The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]. * **<color #00a2e8>UniProt Summary</color>**: N/A <button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button> <button type='primary' size='sm' modal='GO_terms'>GO Terms</button> <modal id='Pfam_Domains' size='lg' title='Pfam Domains'> |Prion| |Prion bPrPp| </modal> <modal id='GO_terms' size='lg' title='GO Terms'> |type 8 metabotropic glutamate receptor binding| |regulation of intracellular calcium activated chloride channel activity| |negative regulation of dendritic spine maintenance| |regulation of calcium ion import across plasma membrane| |cupric ion binding| |type 5 metabotropic glutamate receptor binding| |cuprous ion binding| |regulation of inorganic anion transmembrane transport| |ATP-dependent protein binding| |modulation of age-related behavioral decline| |neuron projection maintenance| |dendritic spine maintenance| |regulation of chloride transport| |regulation of anion channel activity| |negative regulation of activated T cell proliferation| |regulation of dendritic spine maintenance| |negative regulation of long-term synaptic potentiation| |negative regulation of amyloid-beta formation| |negative regulation of interleukin-17 production| |negative regulation of calcineurin-mediated signaling| |negative regulation of calcineurin-NFAT signaling cascade| |cellular copper ion homeostasis| |negative regulation of amyloid precursor protein catabolic process| |lamin binding| |copper ion homeostasis| |inclusion body| |anchored component of external side of plasma membrane| |negative regulation of T cell receptor signaling pathway| |negative regulation of interleukin-2 production| |calcium-mediated signaling using intracellular calcium source| |negative regulation of synapse organization| |glycosaminoglycan binding| |regulation of amyloid-beta formation| |negative regulation of antigen receptor-mediated signaling pathway| |regulation of anion transmembrane transport| |regulation of interleukin-17 production| |negative regulation of calcium-mediated signaling| |cellular response to copper ion| |dendritic spine organization| |positive regulation of protein targeting to membrane| |long-term memory| |negative regulation of interferon-gamma production| |negative regulation of protein processing| |negative regulation of protein maturation| |regulation of amyloid precursor protein catabolic process| |regulation of calcineurin-NFAT signaling cascade| |regulation of calcineurin-mediated signaling| |regulation of activated T cell proliferation| |regulation of protein targeting to membrane| |regulation of calcium ion import| |cellular response to amyloid-beta| |regulation of T cell receptor signaling pathway| |neuron projection organization| |regulation of long-term synaptic potentiation| |response to copper ion| |protein destabilization| |cellular component maintenance| |response to amyloid-beta| |regulation of interleukin-2 production| |tubulin binding| |positive regulation of neuron apoptotic process| |positive regulation of protein tyrosine kinase activity| |positive regulation of protein localization to plasma membrane| |copper ion binding| |negative regulation of T cell proliferation| |positive regulation of protein localization to cell periphery| |regulation of antigen receptor-mediated signaling pathway| |regulation of glutamate receptor signaling pathway| |response to cadmium ion| |extrinsic component of membrane| |regulation of protein processing| |regulation of protein maturation| |negative regulation of mononuclear cell proliferation| |negative regulation of lymphocyte proliferation| |negative regulation of leukocyte proliferation| |regulation of potassium ion transmembrane transport| |amyloid-beta binding| |regulation of protein targeting| |postsynapse| |postsynapse organization| |regulation of protein tyrosine kinase activity| |positive regulation of neuron death| |regulation of protein localization to plasma membrane| |regulation of anion transport| |regulation of potassium ion transport| |regulation of postsynapse organization| |regulation of calcium-mediated signaling| |regulation of calcium ion transport into cytosol| |regulation of interferon-gamma production| |protease binding| |chaperone binding| |cellular transition metal ion homeostasis| |negative regulation of T cell activation| |regulation of protein localization to cell periphery| |memory| |negative regulation of leukocyte cell-cell adhesion| |positive regulation of protein localization to membrane| |ion channel binding| |transition metal ion homeostasis| |negative regulation of lymphocyte activation| |cell cycle arrest| |calcium-mediated signaling| |negative regulation of cellular amide metabolic process| |regulation of calcium ion transmembrane transport| |positive regulation of intracellular protein transport| |regulation of T cell proliferation| |negative regulation of DNA-binding transcription factor activity| |negative regulation of cell-cell adhesion| |negative regulation of leukocyte activation| |negative regulation of cell projection organization| |regulation of synaptic plasticity| |regulation of protein localization to membrane| |positive regulation of peptidyl-tyrosine phosphorylation| |cellular response to metal ion| |negative regulation of cell activation| |signaling receptor activity| |regulation of neuron apoptotic process| |positive regulation of intracellular transport| |regulation of lymphocyte proliferation| |regulation of mononuclear cell proliferation| |regulation of synapse organization| |cellular response to inorganic substance| |regulation of leukocyte proliferation| |membrane raft| |regulation of synapse structure or activity| |regulation of intracellular protein transport| |nuclear membrane| |microtubule binding| |regulation of calcium ion transport| |regulation of peptidyl-tyrosine phosphorylation| |postsynaptic density| |regulation of ion transmembrane transporter activity| |learning or memory| |regulation of transmembrane transporter activity| |protein-containing complex binding| |synapse organization| |negative regulation of cell adhesion| |negative regulation of cytokine production| |regulation of transporter activity| |aging| |regulation of protein stability| |regulation of leukocyte cell-cell adhesion| |cognition| |regulation of neuron death| |regulation of T cell activation| |positive regulation of cellular protein localization| |cellular response to peptide| |activation of protein kinase activity| |regulation of cation transmembrane transport| |second-messenger-mediated signaling| |protein homooligomerization| |regulation of intracellular transport| |negative regulation of proteolysis| |response to metal ion| |response to oxidative stress| |regulation of metal ion transport| |regulation of cell-cell adhesion| |regulation of cellular amide metabolic process| |cellular response to drug| |negative regulation of protein phosphorylation| |dendrite| |positive regulation of protein transport| |regulation of DNA-binding transcription factor activity| |negative regulation of immune system process| |modulation of chemical synaptic transmission| |regulation of trans-synaptic signaling| |negative regulation of phosphorylation| |positive regulation of establishment of protein localization| |response to peptide| |regulation of ion transmembrane transport| |negative regulation of intracellular signal transduction| |regulation of lymphocyte activation| |protein complex oligomerization| |positive regulation of protein kinase activity| |response to inorganic substance| |regulation of cellular protein localization| |cellular metal ion homeostasis| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |regulation of transmembrane transport| |behavior| |negative regulation of cell cycle| |positive regulation of kinase activity| |negative regulation of protein modification process| |cellular response to organonitrogen compound| |regulation of leukocyte activation| |cell surface| |metal ion homeostasis| |cellular cation homeostasis| |regulation of cell activation| |positive regulation of apoptotic process| |cellular ion homeostasis| |positive regulation of programmed cell death| |positive regulation of transferase activity| |cellular response to nitrogen compound| |negative regulation of cell population proliferation| |regulation of cell adhesion| |intracellular membrane-bounded organelle| |regulation of plasma membrane bounded cell projection organization| |regulation of cytokine production| |positive regulation of cell death| |regulation of ion transport| |negative regulation of cellular component organization| |cation homeostasis| |regulation of protein transport| |regulation of cell projection organization| |inorganic ion homeostasis| |regulation of proteolysis| |regulation of peptide transport| |cellular chemical homeostasis| |regulation of establishment of protein localization| |ion homeostasis| |negative regulation of catalytic activity| |regulation of protein kinase activity| |regulation of kinase activity| |negative regulation of apoptotic process| |cellular homeostasis| |negative regulation of programmed cell death| |regulation of cellular localization| |regulation of transferase activity| |Golgi apparatus| |positive regulation of transport| |negative regulation of cell death| |cell cycle process| |response to organonitrogen compound| |endoplasmic reticulum| |positive regulation of protein phosphorylation| |response to drug| |regulation of protein localization| |negative regulation of cellular protein metabolic process| |cellular response to oxygen-containing compound| |positive regulation of phosphorylation| |identical protein binding| |response to nitrogen compound| |negative regulation of protein metabolic process| |chemical homeostasis| |plasma membrane bounded cell projection organization| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |negative regulation of molecular function| |regulation of immune response| |cell projection organization| |regulation of cell cycle| |negative regulation of multicellular organismal process| |cellular response to endogenous stimulus| |positive regulation of protein modification process| |negative regulation of signal transduction| |cell cycle| |negative regulation of cell communication| |negative regulation of signaling| |nervous system process| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |response to endogenous stimulus| |regulation of apoptotic process| |response to oxygen-containing compound| |protein-containing complex assembly| |regulation of programmed cell death| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |negative regulation of response to stimulus| |homeostatic process| |regulation of immune system process| |regulation of cell death| |intracellular signal transduction| |positive regulation of protein metabolic process| |negative regulation of gene expression| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of intracellular signal transduction| |regulation of protein modification process| |protein-containing complex subunit organization| |regulation of transport| |system process| </modal> \\ === CRISPR Data === <button type='primary' size='small' modal='Compound_Hit'>Compound Hit</button> <button type='default' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button> <button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button> <modal id='Compound_Hit' size='lg' title='Compound Hit'> ^Screen^Score^ |[[:results:exp264|Arsenate 40μM R06 exp264]]|-2.1| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|-1.94| |[[:results:exp148|SB202190 10μM R03 exp148]]|-1.93| |[[:results:exp372|Ibrutinib 1μM R07 exp372]]|1.74| </modal> <modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'> No correlation found to any other genes in chemogenomics. </modal> <modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'> Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| </modal> == Essentiality in NALM6 == * **<color #00a2e8>Essentiality Rank</color>**: 6713 * **<color #00a2e8>Expression level (log2 read counts)</color>**: 6.01 <button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button> <modal id='Dist_expr' size='lg' title='PRNP Expression in NALM6 Cells: 6.01'> {{:chemogenomics:nalm6 dist.png?nolink |}} </modal> Last modified: 2025/12/10 20:19by 127.0.0.1